G37.9
BillableDemyelinating disease of central nervous system, unspecified
HCC Category Mapping
V28HCC 198 — Multiple Sclerosis
0.000V24HCC 77 — Multiple Sclerosis
0.476ESRDHCC 77 — Multiple Sclerosis
0.000What This Code Means
A condition involving damage to nerve insulation in the brain and spinal cord where the specific type has not been determined or specified.
Coding Tips
- •This is an unspecified code; use only when the specific demyelinating disease cannot be determined from documentation
- •Query the provider for more specific diagnosis if possible to assign a more precise code from the G37 category
Clinical Significance
Demyelinating disease of the central nervous system, unspecified, is used when a patient has a confirmed CNS demyelinating condition but the specific type has not been determined. This represents a significant documentation improvement opportunity, as identifying the specific demyelinating disease affects treatment decisions and prognosis. It still captures the condition for risk adjustment purposes.
Documentation Requirements
- ✓Documentation confirming a demyelinating disease of the CNS is present
- ✓Neuroimaging supporting the demyelinating nature of the condition
- ✓Evidence that diagnostic workup is ongoing or that specific diagnosis could not be determined
- ✓Neurological examination documenting deficits consistent with CNS demyelination
- ✓Plan for further diagnostic evaluation (antibody testing, follow-up MRI)
Commonly Confused Codes
G35 — Multiple sclerosis; should be used when MS diagnostic criteria are metG37.89 — Other specified demyelinating diseases of CNS; use when a specific type is identifiedG36.0 — Neuromyelitis optica; requires antibody testing to confirmG37.81 — MOGAD; requires MOG antibody testing to confirmR29.818 — Other symptoms and signs involving the nervous system; use for symptoms, not confirmed demyelinating disease
Code Hierarchy
└G37Other demyelinating diseases of central nervous system└G37.9Demyelinating disease of central nervous system, unspecified
└G37.9Demyelinating disease of central nervous system, unspecified